Search results
Merck stops skin cancer combination therapy testing in late-stage study
Reuters· 2 days ago, opens new tab has discontinued testing a combination of an experimental antibody-based drug and...
Merck stops skin cancer combination therapy testing in late-stage study
WSAU Wausau· 2 days ago(Reuters) -Merck has discontinued testing a combination of an experimental antibody-based drug and...
Merck's endometrial cancer therapy fails trial
AOL· 6 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after surgery. The trial did not meet the main ...
Merck's endometrial cancer therapy fails trial
Reuters via AOL· 6 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Merck halts research on combo drug for skin cancer
Becker’s Hospital Review· 2 days agoMerck will stop testing an experimental combination treatment for skin cancer patients in a late-stage study, the drugmaker said May 13. Merck was evaluating ...
Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study
Morningstar· 2 days agoMerck & Co. has ended part of a late-stage study of a co-formulation of its blockbuster cancer drug Keytruda in certain skin-cancer patients because the study was likely to ...
Years After His Death, a Late Scientist’s Work Has Opened the Door for Life-Saving New Cancer...
SciTechDaily· 2 hours agoThe final work of a late scientist from the University of Virginia School of Medicine has paved the...
Tri-Cities doctor fined after prescribing ivermectin for COVID. 2nd physician charged
Tri-City Herald McClatchy via AOL· 4 days agoOne doctor joined in a lawsuit against the Washington Medical Commission with the help of the Silent...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 7 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Merck stops skin cancer combination therapy testing in late-stage study
Reuters via Yahoo Finance· 2 days agoMay 13 (Reuters) - Merck said on Monday it had discontinued the arm of a late-stage study, which tested an experimental antibody-based drug with its blockbuster immunotherapy ...
